Snapshot from Jul 07, 2026 at 01:18 UTC. For live data and tracking: View Live
Entity

Novartis — Sandoz

Tracked across 3 events · 21 articles · First seen Oct 29, 2025 · Last active Jun 30, 2026

Sentiment
3
Attention
4
Events
3
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 10
Tech
Impact: Novartis — Sandoz validated the J.TRAIN model through a December 2025 transaction, which included a manufacturing facility and a license to Evotec's proprietary manufacturing technology, demonstrating the feasibility and scalability of the new offering.
Jun 30, 2026 · 7 articles
4 0
Business
Impact: Novartis — Sandoz expanded its development and commercialization partnership with Samsung Biologics — Samsung Biologics for biosimilar candidates.
Apr 23, 2026 · 6 articles
4 0
Regulatory
Impact: Novartis — Sandoz is mentioned as a company that has previously recalled drugs due to nitrosamine contamination, providing context to the current event.
Oct 29, 2025 · 8 articles
ERGEN INTELLIGENCE
Track Novartis — Sandoz live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.